Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Read more
Novartis’ Rhapsido Approved by FDA as First Oral BTK Inhibitor for Chronic Spontaneous Urticaria Read more
AstraZeneca and Daiichi Sankyo’s Enhertu Shows Strong Phase III Results in HER2-Positive Early Breast Cancer Read more